The information provided in this report is taken from www.sec.gov and many other data providers. While we have conducted our best efforts to ensure that the parsed data is accurate, we cannot guarantee its accuracy. Please use caution and understand that any consequences of its use are your own responsibility.
Forma Therapeutics Holdings, Inc(NASDAQ:FMTX)


Forma Therapeutics Holdings, Inc., a clinical-stage biopharmaceutical company, focuses on development and commercialization of novel therapeutics for treatment of rare hematologic diseases and cancers. Its core product candidates for development include FT-4202, which is Phase 1 trial for the treatm...
Website: https://www.formatherapeutics.com/
Founded: 2007
Full Time Employees: 114 (May 2021)
CEO: Frank D. Lee
Sector: Healthcare
Industry: Biotechnology
Share this website to your friends
Forma Therapeutics Days Receivable Outstanding ttm (DSO)
Forma Therapeutics Op Cashflow Per Share ttm
Forma Therapeutics Free Cashflow Per Share ttm
Forma Therapeutics Cash Per Share ttm
Forma Therapeutics P/S ratio ttm
Forma Therapeutics (GAAP) P/E ratio ttm
Forma Therapeutics P/B ratio ttm
No extra charts and metrics for this ticker.